New York State Common Retirement Fund
JBIO

New York State Common Retirement Fund’s Jade Biosciences JBIO Stock Holding History

New York State Common Retirement Fund’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$104K Sell
7,422
-7,200
-49% -$104K ﹤0.01% 2505
2025
Q4 		$226K Buy
14,622
+9,400
+180% +$110K ﹤0.01% 2245
2025
Q3 		$45.1K Buy
5,222
+5,100
+4,180% +$41.7K ﹤0.01% 2978
2025
Q2 		$1.22K Sell
122
-1
-0.8% -$34 ﹤0.01% 3193
2025
Q1 		$10.8K Hold
123
– – ﹤0.01% 3073
2024
Q4 		$11.4K Hold
123
– – ﹤0.01% 3102
2024
Q3 		$8.97K Hold
123
– – ﹤0.01% 3116
2024
Q2 		$7.13K Hold
123
– – ﹤0.01% 3243
2024
Q1 		$128K Hold
123
– – ﹤0.01% 2639
2023
Q4 		$97.4K Hold
123
– – ﹤0.01% 2760
2023
Q3 		$58.6K Buy
123
+1
+0.8% +$542 ﹤0.01% 2969
2023
Q2 		$73.3K Sell
122
-98
-45% -$62.7K ﹤0.01% 3031
2023
Q1 		$155K Buy
220
+1
+0.5% +$829 ﹤0.01% 2697
2022
Q4 		$225K Sell
219
-1
-0.5% -$726 ﹤0.01% 2683
2022
Q3 		$127K Buy
220
+72
+49% +$48.1K ﹤0.01% 2937
2022
Q2 		$81K Sell
148
-212
-59% -$101K ﹤0.01% 3144
2022
Q1 		$231K Buy
360
+224
+165% +$86.9K ﹤0.01% 2769
2021
Q4 		$56K Buy
136
+85
+167% +$43K ﹤0.01% 3198
2021
Q3 		$38K Buy
+51
New +$28.6K ﹤0.01% 3267

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

New York State Common Retirement Fund's JBIO Position: Q1 2026 in Review

New York State Common Retirement Fund reduced its Jade Biosciences (JBIO) stake by 49% in Q1 2026, selling an estimated $104K and leaving 7,422 shares worth $104K. The position accounts for ﹤0.01% of the portfolio, ranked #2505.

New York State Common Retirement Fund first reported a position in JBIO in Q3 2021 and has held it in 19 quarters since. The position peaked at $231K in Q1 2022. 120 funds tracked by Wall St. Rank hold JBIO as of Q1 2026.

  • New York State Common Retirement Fund held 7,422 shares of Jade Biosciences worth $104K as of Q1 2026.
  • New York State Common Retirement Fund sold 7,200 Jade Biosciences shares in Q1 2026, an estimated $104K.
  • Jade Biosciences made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q1 2026, its #2505 holding.
  • New York State Common Retirement Fund first reported a position in Jade Biosciences in Q3 2021 and has held it in 19 quarters since.
  • New York State Common Retirement Fund's Jade Biosciences position peaked at $231K in Q1 2022.
  • 120 funds tracked by Wall St. Rank held Jade Biosciences as of Q1 2026.

Based on New York State Common Retirement Fund's 13F filing for Q1 2026, filed 6 May 2026.